Technetium: Clinical Trials

5 trials of Technetium, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting, 1 terminated. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 3, Not yet recruiting 1, Terminated 1

Follow Technetium: new trials by email Literature Review of Technetium trials Research Report on Technetium

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Superparamagnetic Iron Oxide for Sentinel Lymph Node Localization in Patients With Cutaneous Melanoma: MagMen-II
Superparamagnetic Iron Oxide, Technetium (99mTc) - Melanoma (Skin Cancer)
Phase 3Not yet recruitingVastra Gotaland Region2542026-10-012026-09-03
99mTc-3PRGD2 SPECT/CT for Integrin Imaging of Lung Cancer
99mTc-3PRGD2 injection - Lung Cancer, Lymph Node Metastasis
Phase 3CompletedRDO Pharm.4092019-10-122024-07-01
Study Assessing The Interest of Indocyanine Green Fluorescence Imaging With Radioisotope Method For Sentinel Lymph Node Biopsy in Patients With Breast Cancer
indocyanine green, isotope - Breast Neoplasms
Phase 3CompletedCentre Hospitalier Universitaire de Saint Etienne992014-11-012018-04-09
Compare Technegas Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging for Pulmonary Embolism
Technegas V SPECT imaging, Xenon-133 Ventilation Planar imaging - Pulmonary Embolism
Phase 3TerminatedCyclomedica Australia PTY Limited182012-08-012015-11-10
Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
regadenoson, overencapsulated caffeine, technetium - Coronary Artery Disease (CAD)
Phase 3CompletedAstellas Pharma Inc3472009-03-242024-12-03

Conditions studied

Breast Neoplasms (1)  ·  Coronary Artery Disease (1)  ·  Ischemia (1)  ·  Lung Neoplasms (1)  ·  Lymphatic Metastasis (1)  ·  Melanoma (1)  ·  Pulmonary Embolism (1)

Sponsors

Astellas Pharma Inc (1)  ·  Centre Hospitalier Universitaire de Saint Etienne (1)  ·  Cyclomedica Australia PTY Limited (1)  ·  RDO Pharm. (1)  ·  Vastra Gotaland Region (1)

Countries

United States (2)  ·  China (1)  ·  France (1)

Top investigators

Akash Sharma, MD (1)  ·  David Leung, MD, PhD (1)  ·  Edward M Aten, MD (1)  ·  Zhaohui Zhu, MD, PhD (1)

Results publications

PMID 21082298

NIH funding

2014 (1)